21 min listen
Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski
FromThe Hematologist
Is Dose-adjusted EPOCH-R Enough for Burkitt Lymphoma? With Drs. Brad Kahl and Mark Roschewski
FromThe Hematologist
ratings:
Length:
14 minutes
Released:
Nov 2, 2020
Format:
Podcast episode
Description
In this podcast, Contributing Editor Dr. Brad Kahl has a conversation with Dr. Mark Roschewski. They discuss Dr. Kahl's Diffusion article from the November/December 2020 issue of The Hematologist, titled, "Is Dose-adjusted EPOCH-R Enough in Burkitt Lymphoma?" They discuss a study that evaluates the efficacy of the dose-adjusted EPOCH-R regimen in adult patients with Burkitt lymphoma. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/472152/Is-Dose-adjusted-EPOCH-R-Enough-in-Burkitt.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Nov 2, 2020
Format:
Podcast episode
Titles in the series (100)
The Year's Best in Sickle Cell Disease with Dr. Alexis Thompson and Dr. Jason Gotlib: The first podcast of 2017 for The Hematologist: ASH News and Reports features Dr. Jason Gotlib (Stanford University School of Medicine) and Dr. Alexis Thompson (Ann and Robert H. Lurie Children's Hospital) having a conversation about the highlights of 201 by The Hematologist